Copyright Reports & Markets. All rights reserved.

Global Guanine for Pharmaceuticals Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Purity
    • 1.3.1 Overview: Global Guanine for Pharmaceuticals Consumption Value by Purity: 2020 Versus 2024 Versus 2031
    • 1.3.2 above 99%
    • 1.3.3 above 99.5%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Guanine for Pharmaceuticals Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Antiviral Medicine Intermediates
    • 1.4.3 Other Medicine Synthesis
  • 1.5 Global Guanine for Pharmaceuticals Market Size & Forecast
    • 1.5.1 Global Guanine for Pharmaceuticals Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Guanine for Pharmaceuticals Sales Quantity (2020-2031)
    • 1.5.3 Global Guanine for Pharmaceuticals Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Hubei Hongyuan Pharmaceutical Technology
    • 2.1.1 Hubei Hongyuan Pharmaceutical Technology Details
    • 2.1.2 Hubei Hongyuan Pharmaceutical Technology Major Business
    • 2.1.3 Hubei Hongyuan Pharmaceutical Technology Guanine for Pharmaceuticals Product and Services
    • 2.1.4 Hubei Hongyuan Pharmaceutical Technology Guanine for Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Hubei Hongyuan Pharmaceutical Technology Recent Developments/Updates
  • 2.2 Weifang Aotong Pharmaceutical
    • 2.2.1 Weifang Aotong Pharmaceutical Details
    • 2.2.2 Weifang Aotong Pharmaceutical Major Business
    • 2.2.3 Weifang Aotong Pharmaceutical Guanine for Pharmaceuticals Product and Services
    • 2.2.4 Weifang Aotong Pharmaceutical Guanine for Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Weifang Aotong Pharmaceutical Recent Developments/Updates
  • 2.3 Zhejiang Oma Pharmaceutical
    • 2.3.1 Zhejiang Oma Pharmaceutical Details
    • 2.3.2 Zhejiang Oma Pharmaceutical Major Business
    • 2.3.3 Zhejiang Oma Pharmaceutical Guanine for Pharmaceuticals Product and Services
    • 2.3.4 Zhejiang Oma Pharmaceutical Guanine for Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Zhejiang Oma Pharmaceutical Recent Developments/Updates
  • 2.4 Changzhou Kangrui Chemicals
    • 2.4.1 Changzhou Kangrui Chemicals Details
    • 2.4.2 Changzhou Kangrui Chemicals Major Business
    • 2.4.3 Changzhou Kangrui Chemicals Guanine for Pharmaceuticals Product and Services
    • 2.4.4 Changzhou Kangrui Chemicals Guanine for Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Changzhou Kangrui Chemicals Recent Developments/Updates
  • 2.5 Hubei Yitai Pharmaceutical
    • 2.5.1 Hubei Yitai Pharmaceutical Details
    • 2.5.2 Hubei Yitai Pharmaceutical Major Business
    • 2.5.3 Hubei Yitai Pharmaceutical Guanine for Pharmaceuticals Product and Services
    • 2.5.4 Hubei Yitai Pharmaceutical Guanine for Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Hubei Yitai Pharmaceutical Recent Developments/Updates
  • 2.6 Xiangyang Extenda Biotech
    • 2.6.1 Xiangyang Extenda Biotech Details
    • 2.6.2 Xiangyang Extenda Biotech Major Business
    • 2.6.3 Xiangyang Extenda Biotech Guanine for Pharmaceuticals Product and Services
    • 2.6.4 Xiangyang Extenda Biotech Guanine for Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Xiangyang Extenda Biotech Recent Developments/Updates
  • 2.7 Shandong Minglang Chemical
    • 2.7.1 Shandong Minglang Chemical Details
    • 2.7.2 Shandong Minglang Chemical Major Business
    • 2.7.3 Shandong Minglang Chemical Guanine for Pharmaceuticals Product and Services
    • 2.7.4 Shandong Minglang Chemical Guanine for Pharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Shandong Minglang Chemical Recent Developments/Updates

3 Competitive Environment: Guanine for Pharmaceuticals by Manufacturer

  • 3.1 Global Guanine for Pharmaceuticals Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Guanine for Pharmaceuticals Revenue by Manufacturer (2020-2025)
  • 3.3 Global Guanine for Pharmaceuticals Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Guanine for Pharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Guanine for Pharmaceuticals Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Guanine for Pharmaceuticals Manufacturer Market Share in 2024
  • 3.5 Guanine for Pharmaceuticals Market: Overall Company Footprint Analysis
    • 3.5.1 Guanine for Pharmaceuticals Market: Region Footprint
    • 3.5.2 Guanine for Pharmaceuticals Market: Company Product Type Footprint
    • 3.5.3 Guanine for Pharmaceuticals Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Guanine for Pharmaceuticals Market Size by Region
    • 4.1.1 Global Guanine for Pharmaceuticals Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Guanine for Pharmaceuticals Consumption Value by Region (2020-2031)
    • 4.1.3 Global Guanine for Pharmaceuticals Average Price by Region (2020-2031)
  • 4.2 North America Guanine for Pharmaceuticals Consumption Value (2020-2031)
  • 4.3 Europe Guanine for Pharmaceuticals Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Guanine for Pharmaceuticals Consumption Value (2020-2031)
  • 4.5 South America Guanine for Pharmaceuticals Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Guanine for Pharmaceuticals Consumption Value (2020-2031)

5 Market Segment by Purity

  • 5.1 Global Guanine for Pharmaceuticals Sales Quantity by Purity (2020-2031)
  • 5.2 Global Guanine for Pharmaceuticals Consumption Value by Purity (2020-2031)
  • 5.3 Global Guanine for Pharmaceuticals Average Price by Purity (2020-2031)

6 Market Segment by Application

  • 6.1 Global Guanine for Pharmaceuticals Sales Quantity by Application (2020-2031)
  • 6.2 Global Guanine for Pharmaceuticals Consumption Value by Application (2020-2031)
  • 6.3 Global Guanine for Pharmaceuticals Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Guanine for Pharmaceuticals Sales Quantity by Purity (2020-2031)
  • 7.2 North America Guanine for Pharmaceuticals Sales Quantity by Application (2020-2031)
  • 7.3 North America Guanine for Pharmaceuticals Market Size by Country
    • 7.3.1 North America Guanine for Pharmaceuticals Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Guanine for Pharmaceuticals Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Guanine for Pharmaceuticals Sales Quantity by Purity (2020-2031)
  • 8.2 Europe Guanine for Pharmaceuticals Sales Quantity by Application (2020-2031)
  • 8.3 Europe Guanine for Pharmaceuticals Market Size by Country
    • 8.3.1 Europe Guanine for Pharmaceuticals Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Guanine for Pharmaceuticals Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Guanine for Pharmaceuticals Sales Quantity by Purity (2020-2031)
  • 9.2 Asia-Pacific Guanine for Pharmaceuticals Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Guanine for Pharmaceuticals Market Size by Region
    • 9.3.1 Asia-Pacific Guanine for Pharmaceuticals Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Guanine for Pharmaceuticals Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Guanine for Pharmaceuticals Sales Quantity by Purity (2020-2031)
  • 10.2 South America Guanine for Pharmaceuticals Sales Quantity by Application (2020-2031)
  • 10.3 South America Guanine for Pharmaceuticals Market Size by Country
    • 10.3.1 South America Guanine for Pharmaceuticals Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Guanine for Pharmaceuticals Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Guanine for Pharmaceuticals Sales Quantity by Purity (2020-2031)
  • 11.2 Middle East & Africa Guanine for Pharmaceuticals Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Guanine for Pharmaceuticals Market Size by Country
    • 11.3.1 Middle East & Africa Guanine for Pharmaceuticals Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Guanine for Pharmaceuticals Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Guanine for Pharmaceuticals Market Drivers
  • 12.2 Guanine for Pharmaceuticals Market Restraints
  • 12.3 Guanine for Pharmaceuticals Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Guanine for Pharmaceuticals and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Guanine for Pharmaceuticals
  • 13.3 Guanine for Pharmaceuticals Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Guanine for Pharmaceuticals Typical Distributors
  • 14.3 Guanine for Pharmaceuticals Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Guanine for Pharmaceuticals market size was valued at US$ 41.2 million in 2024 and is forecast to a readjusted size of USD 54.7 million by 2031 with a CAGR of 4.2% during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Guanine is a naturally occurring organic compound that belongs to the family of purine bases. It is one of the four building blocks of DNA and RNA, along with adenine, cytosine, and thymine (in DNA) or uracil (in RNA). Guanine is also found in other nucleotides like GTP (guanosine triphosphate) and GDP (guanosine diphosphate), which are essential for various cellular processes. In pharmaceutical fields, guanine is mainly used as antiviral drug's intermediates.
    This report is a detailed and comprehensive analysis for global Guanine for Pharmaceuticals market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Purity and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Guanine for Pharmaceuticals market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2020-2031
    Global Guanine for Pharmaceuticals market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2020-2031
    Global Guanine for Pharmaceuticals market size and forecasts, by Purity and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2020-2031
    Global Guanine for Pharmaceuticals market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (US$/Kg), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Guanine for Pharmaceuticals
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Guanine for Pharmaceuticals market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hubei Hongyuan Pharmaceutical Technology, Weifang Aotong Pharmaceutical, Zhejiang Oma Pharmaceutical, Changzhou Kangrui Chemicals, Hubei Yitai Pharmaceutical, Xiangyang Extenda Biotech, Shandong Minglang Chemical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Guanine for Pharmaceuticals market is split by Purity and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Purity, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Purity
    above 99%
    above 99.5%
    Market segment by Application
    Antiviral Medicine Intermediates
    Other Medicine Synthesis
    Major players covered
    Hubei Hongyuan Pharmaceutical Technology
    Weifang Aotong Pharmaceutical
    Zhejiang Oma Pharmaceutical
    Changzhou Kangrui Chemicals
    Hubei Yitai Pharmaceutical
    Xiangyang Extenda Biotech
    Shandong Minglang Chemical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Guanine for Pharmaceuticals product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Guanine for Pharmaceuticals, with price, sales quantity, revenue, and global market share of Guanine for Pharmaceuticals from 2020 to 2025.
    Chapter 3, the Guanine for Pharmaceuticals competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Guanine for Pharmaceuticals breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Purity and by Application, with sales market share and growth rate by Purity, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Guanine for Pharmaceuticals market forecast, by regions, by Purity, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Guanine for Pharmaceuticals.
    Chapter 14 and 15, to describe Guanine for Pharmaceuticals sales channel, distributors, customers, research findings and conclusion.

    Buy now